OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 29, 2021
CuriRx’s CuriLytics platform is a mass spectrometry instrument that will support complex biotherapeutics development.
July 15, 2021
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.
Microfluidic Modulation Spectroscopy is a recent innovation in infrared spectroscopy techniques that improves elucidation of secondary protein structure.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.
March 02, 2021
The need for real-time monitoring and control has spurred the development of new analytical tools.
January 28, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
June 29, 2020
Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.
May 01, 2020
In this peer-reviewed article, the authors present a series of experimental studies showcasing the performance of MMS in secondary-structure biopharma characterization and compare it with conventional FTIR data.
February 01, 2020
Analytical solutions are improving for raw material testing, process development, drug product release, and more.